In the ob/ob model of diabetes and NASH, oral administration of Imm124E decreased serum TNF-α levels, and increased the number of splenic CD4+CD25+, CD4+CD25+Foxp3+ Tregs, and NKT cells. Here, CD4 is linked to metabolic dysfunction-associated steatohepatitis.